TB-500 + BPC-157 + GHK-Cu

A three-in-one healing combo that adds GHK-Cu (copper peptide) to the BPC-157 and TB-500 stack. GHK-Cu helps build collagen, remodel tissue, and fight oxidative damage, complementing the repair and anti-inflammatory effects of the other two. An advanced protocol for comprehensive tissue healing and recovery.

Dosage

Combined dose subcutaneous 2-3x weekly (varies by formulation)

Dosages shown are for research reference only. Always consult a qualified healthcare provider.

Half-Life

BPC-157: 4 hours | TB-500: 2-3 hours | GHK-Cu: 1-2 hours

Half-Life Calculator →

Shop Research-Grade Peptides

99%+ purity · US-based · third-party lab tested

Browse →

Getting Started — Here's What You'll Need

Effects

Comprehensive Healing

Three-layer synergy: cell migration, growth factors, and tissue remodeling.

Collagen Quality

GHK-Cu promotes organized connective tissue rather than scar formation.

Mechanism of Action

This triple combination adds the copper peptide GHK-Cu to the BPC-157/TB-500 healing stack, introducing a third distinct mechanism — copper-dependent enzymatic tissue remodeling — alongside the NO/growth factor signaling of BPC-157 and the actin-mediated cell migration of TB-500.

GHK-Cu contributes uniquely through its ability to deliver bioavailable copper to cells and activate copper-dependent enzymes. Lysyl oxidase, a copper-dependent enzyme, catalyzes the cross-linking of collagen and elastin fibers, which is essential for creating organized, structurally sound connective tissue rather than disorganized scar tissue. Superoxide dismutase (SOD), another copper-dependent enzyme, provides antioxidant defense at the wound site, protecting newly forming tissue from oxidative damage. GHK-Cu also stimulates the synthesis of collagen types I and III, elastin, glycosaminoglycans, and decorin — the fundamental building blocks of the extracellular matrix.

The theoretical three-layer synergy works as follows: TB-500 acts first by mobilizing repair cells through actin regulation and reducing acute inflammation. BPC-157 creates the vascular and biochemical infrastructure for repair through angiogenesis and growth factor upregulation. GHK-Cu then supports the remodeling phase — the final stage of wound healing where disorganized early repair tissue is replaced with properly structured, functional tissue. GHK-Cu's gene-regulatory effects (modulating expression of over 4,000 genes) may also amplify the effects of the other two peptides by creating a favorable transcriptional environment for regeneration. As with the dual BPC/TB stack, no clinical data exists for this specific triple combination.

Regulatory Status

Not FDA approved. Combination product from compounding pharmacies and peptide suppliers.

Risks & Safety

Common

injection site irritation, nausea, headache, temporary fatigue.

Serious

theoretical risk of promoting existing tumors since all three peptides stimulate cell growth and new blood vessel formation; no data on interactions between three bioactive compounds used together.

Rare

allergic reactions, copper-related effects from the GHK-Cu component.

Compare TB-500 + BPC-157 + GHK-Cu With

Research Papers

2
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.

Published: December 31, 2025

AI Summary

A broad review explains how wound-healing peptides like TB-500, BPC-157, and GHK-Cu support tissue repair, inflammation control, and nerve recovery in musculoskeletal care. While animal studies look promising, human clinical trials are still lacking.

Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians.

Published: December 31, 2025

AI Summary

A primer for orthopaedic surgeons on injectable therapeutic peptides, given the growing market and patient interest. The paper emphasizes the need to understand current evidence before recommending these compounds.

Frequently Asked Questions

What is TB-500 + BPC-157 + GHK-Cu?

A three-in-one healing combo that adds GHK-Cu (copper peptide) to the BPC-157 and TB-500 stack. GHK-Cu helps build collagen, remodel tissue, and fight oxidative damage, complementing the repair and anti-inflammatory effects of the other two. An advanced protocol for comprehensive tissue healing and recovery.

What is TB-500 + BPC-157 + GHK-Cu used for?

A three-in-one healing combo that adds GHK-Cu (copper peptide) to the BPC-157 and TB-500 stack. GHK-Cu helps build collagen, remodel tissue, and fight oxidative damage, complementing the repair and anti-inflammatory effects of the other two. An advanced protocol for comprehensive tissue healing and recovery.

What is the dosage for TB-500 + BPC-157 + GHK-Cu?

Varies by supplier formulation. Typical: combined dose subcutaneous two or three times weekly for 4-8 weeks. Individual component doses are generally lower than standalone use due to synergistic effects.

What are the side effects of TB-500 + BPC-157 + GHK-Cu?

Common: injection site irritation, nausea, headache, temporary fatigue. Serious: theoretical risk of promoting existing tumors since all three peptides stimulate cell growth and new blood vessel formation; no data on interactions between three bioactive compounds used together. Rare: allergic reactions, copper-related effects from the GHK-Cu component.

How does TB-500 + BPC-157 + GHK-Cu work?

This triple combination adds the copper peptide GHK-Cu to the BPC-157/TB-500 healing stack, introducing a third distinct mechanism — copper-dependent enzymatic tissue remodeling — alongside the NO/growth factor signaling of BPC-157 and the actin-mediated cell migration of TB-500. GHK-Cu contributes uniquely through its ability to deliver bioavailable copper to cells and activate copper-dependent enzymes. Lysyl oxidase, a copper-dependent enzyme, catalyzes the cross-linking of collagen and elastin fibers, which is essential for creating organized, structurally sound connective tissue rather than disorganized scar tissue. Superoxide dismutase (SOD), another copper-dependent enzyme, provides antioxidant defense at the wound site, protecting newly forming tissue from oxidative damage. GHK-Cu also stimulates the synthesis of collagen types I and III, elastin, glycosaminoglycans, and decorin — the fundamental building blocks of the extracellular matrix. The theoretical three-layer synergy works as follows: TB-500 acts first by mobilizing repair cells through actin regulation and reducing acute inflammation. BPC-157 creates the vascular and biochemical infrastructure for repair through angiogenesis and growth factor upregulation. GHK-Cu then supports the remodeling phase — the final stage of wound healing where disorganized early repair tissue is replaced with properly structured, functional tissue. GHK-Cu's gene-regulatory effects (modulating expression of over 4,000 genes) may also amplify the effects of the other two peptides by creating a favorable transcriptional environment for regeneration. As with the dual BPC/TB stack, no clinical data exists for this specific triple combination.

How is TB-500 + BPC-157 + GHK-Cu administered?

TB-500 + BPC-157 + GHK-Cu is administered via subcutaneous injection.

What is the half-life of TB-500 + BPC-157 + GHK-Cu?

The half-life of TB-500 + BPC-157 + GHK-Cu is BPC-157: 4 hours | TB-500: 2-3 hours | GHK-Cu: 1-2 hours.

Is TB-500 + BPC-157 + GHK-Cu legal?

Not FDA approved. Combination product from compounding pharmacies and peptide suppliers.

Related Peptides